Agnieszka Boesen

Array ( [id] => 7285898 [patent_doc_number] => 20040146523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Use of the protein uk114 for the treatment and the prevention of chronic active hepatitis' [patent_app_type] => new [patent_app_number] => 10/474364 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1082 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146523.pdf [firstpage_image] =>[orig_patent_app_number] => 10474364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334116 [patent_doc_number] => 07507527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Detection of human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 10/795580 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 7 [patent_no_of_words] => 5320 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507527.pdf [firstpage_image] =>[orig_patent_app_number] => 10795580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7148207 [patent_doc_number] => 20040170647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Recombinant adenovirus vaccines' [patent_app_type] => new [patent_app_number] => 10/794876 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12298 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20040170647.pdf [firstpage_image] =>[orig_patent_app_number] => 10794876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181368 [patent_doc_number] => 20040202676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Method for obtaining antigenic aggregates and the use thereof in formulations' [patent_app_type] => new [patent_app_number] => 10/433492 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4558 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202676.pdf [firstpage_image] =>[orig_patent_app_number] => 10433492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 846944 [patent_doc_number] => 07384643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Recombinant poxvirus' [patent_app_type] => utility [patent_app_number] => 10/781262 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10362 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384643.pdf [firstpage_image] =>[orig_patent_app_number] => 10781262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095482 [patent_doc_number] => 20070117091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Anti-candida agents for the treatment of prion diseases' [patent_app_type] => utility [patent_app_number] => 10/544748 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 9183 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117091.pdf [firstpage_image] =>[orig_patent_app_number] => 10544748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830286 [patent_doc_number] => 07399840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Proteosome influenza vaccine' [patent_app_type] => utility [patent_app_number] => 10/771737 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9681 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399840.pdf [firstpage_image] =>[orig_patent_app_number] => 10771737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432043 [patent_doc_number] => 07264816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Virulent systemic feline calicivirus' [patent_app_type] => utility [patent_app_number] => 10/769531 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 11687 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/264/07264816.pdf [firstpage_image] =>[orig_patent_app_number] => 10769531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314957 [patent_doc_number] => 07524927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Compositions, method and kits relating to deletion mutations of immunodeficiency virus gp120 hypervariable regions' [patent_app_type] => utility [patent_app_number] => 10/767648 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 61 [patent_no_of_words] => 58964 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524927.pdf [firstpage_image] =>[orig_patent_app_number] => 10767648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938398 [patent_doc_number] => 20080075717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Antigen Imitating Extracellular Areas of Membrane Proteins of Type III Produced from Intracellular Pathogenic Micro-Organisms, Derived Conformational Antibodies and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 10/544081 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13953 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075717.pdf [firstpage_image] =>[orig_patent_app_number] => 10544081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 373118 [patent_doc_number] => 07473421 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-06 [patent_title] => 'Humanized anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 10/766773 [patent_app_country] => US [patent_app_date] => 2004-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 64 [patent_no_of_words] => 33526 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/473/07473421.pdf [firstpage_image] =>[orig_patent_app_number] => 10766773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 586765 [patent_doc_number] => 07442775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'Humanized anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 10/766610 [patent_app_country] => US [patent_app_date] => 2004-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 65 [patent_no_of_words] => 35229 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442775.pdf [firstpage_image] =>[orig_patent_app_number] => 10766610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149764 [patent_doc_number] => 20040171071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Method for separating and/or detecting and/or identifying and/or quantifying prion proteins' [patent_app_type] => new [patent_app_number] => 10/482378 [patent_app_country] => US [patent_app_date] => 2003-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8239 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171071.pdf [firstpage_image] =>[orig_patent_app_number] => 10482378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028014 [patent_doc_number] => 20070269461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Recombinant Vaccine Against Japanese Encephalitis Virus (Jev) Infection and a Method Thereof' [patent_app_type] => utility [patent_app_number] => 10/585042 [patent_app_country] => US [patent_app_date] => 2003-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14512 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269461.pdf [firstpage_image] =>[orig_patent_app_number] => 10585042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608046 [patent_doc_number] => 20060269562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'POLYPEPTIDES F\' OF THE HEPATITIS C VIRUS, T EPITOPEO, AND THE DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 10/541353 [patent_app_country] => US [patent_app_date] => 2003-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 50149 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269562.pdf [firstpage_image] =>[orig_patent_app_number] => 10541353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386265 [patent_doc_number] => 20040180367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Antibodies For discrimination of prions' [patent_app_type] => new [patent_app_number] => 10/740025 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11562 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180367.pdf [firstpage_image] =>[orig_patent_app_number] => 10740025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7422288 [patent_doc_number] => 20040229280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Prion protein ligands and methods of use' [patent_app_type] => new [patent_app_number] => 10/727335 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16984 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229280.pdf [firstpage_image] =>[orig_patent_app_number] => 10727335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210005 [patent_doc_number] => 20070248589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Spatial for Altering Cell Proliferation' [patent_app_type] => utility [patent_app_number] => 10/579879 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 39289 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248589.pdf [firstpage_image] =>[orig_patent_app_number] => 10579879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4441088 [patent_doc_number] => 07927793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Cell lines and host nucleic acid sequences related to infectious disease' [patent_app_type] => utility [patent_app_number] => 10/535523 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 41836 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/927/07927793.pdf [firstpage_image] =>[orig_patent_app_number] => 10535523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405600 [patent_doc_number] => 20040175775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Method of detecting PrPsc in eye fluid' [patent_app_type] => new [patent_app_number] => 10/704228 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3328 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175775.pdf [firstpage_image] =>[orig_patent_app_number] => 10704228 [rel_patent_id] =>[rel_patent_doc_number] =>)